uridine monophosphate has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, S; Che, XF; Furukawa, T; Ikeda, R; Kanekura, T; Kanzaki, T; Mataki, H; Matsushita, S; Minami, K; Miyadera, K; Nishizawa, Y; Tabata, S; Tajitsu, Y; Takeda, Y; Ushiyama, M; Yamada, K; Yamamoto, M | 1 |
| Arbel, M; Ben-Schachar, M; Cohen, Y; Epelbaum, R; Klein, B; Kuten, A; Robinson, E; Stein, M; Wajsbort, R | 1 |
2 other study(ies) available for uridine monophosphate and Carcinoma, Anaplastic
| Article | Year |
|---|---|
The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
Topics: Antimetabolites, Antineoplastic; Carcinoma; Cell Line, Tumor; Dideoxynucleotides; Early Growth Response Protein 1; Fluorodeoxyuridylate; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Skin Neoplasms; Stomach Neoplasms; Thrombospondin 1; Thymidine Phosphorylase; Uridine Monophosphate | 2010 |
Carcinoma of the nasopharynx in Northern Israel: epidemiology and treatment results.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Child; Female; Humans; Israel; Jews; Male; Middle Aged; Nasopharyngeal Neoplasms; Prognosis; Radiotherapy Dosage; Uridine Monophosphate | 1988 |